N-Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 10(30), p. 743-767, 2020

Journal article published in 2020 by Hazem Ahmed

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by